期刊名称：ONCOLOGY LETTERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Oncology Letters is indexed and/or abstracted in:
Biological Abstracts® (Thomson ISI)
BIOSIS Previews® (Thomson ISI)
Chemical Abstracts Service (CAS)
EMBASE (Elsevier)
Google Scholar
Index Copernicus (IC)
Science Citation Index Expanded® (Thomson ISI)
Scopus (Elsevier)
Instructions to Authors
Prior to submitting your manuscript, please ensure that it has been prepared according to the guidelines below, with special emphasis on the style of presentation of the Author affiliations and the reference list.
For detailed instructions regarding the preparation of figures, please click on the following link:
Electronic Figure Submission
Manuscripts may be submitted using one of the three methods listed below.
!!! NOTE:Please do NOT submit the same manuscript several times via different methods.
Submission methods:
Online Submission:
Submissions may be uploaded via our online submission system. Click here to access the system, log in or create an account, and follow the onscreen directions.
E-mail submission:
Submissions should be sent to .
Attachments should include:
A completed submission form (interactive PDF; type to fill in). Click here to download the submission form.
Text and tables in one Microsoft Word (.doc) file.
Illustrations as separate .tiff files.
Any additional files, such as a cover letter or conflict of interest statement.
Submission guidelines:
Cover letter: Summarize briefly the main importance of the submitted work.
Format: Original work and review articles concerning fields of recognisable progress are accepted for evaluation. Manuscripts should be written in clear, concise English and should contain all essential data in order to make the presentation clear.
General style: Title of the work, sub-titles and general headlines should be presented in lower case letters (not capitals). Indicate affiliations of the Authors by number (not symbols). Abstract should be continuous (without reference numbers, or headlines).
Manuscripts: Submitted manuscripts should include abstract, text, figures and references. Manuscripts reporting experimental results should be divided into the following sections: (a) First page should include the title of the presented work, full names and full postal addresses of all Authors, name and the e-mail address of the Author to whom correspondence is to be sent, key words and an abbreviated running title; (b) Abstract of approximately 150-300 words; (c) Introduction; (d) Materials and methods; (e) Results; (f) Discussion; (g) Acknowledgements and (h) References. The pages should be numbered consecutively. Footnotes should not be used.
Reviews: Review articles may have different sections and headlines according to the subject matter and the Author"s opinion; however, an Abstract is mandatory. The main headlines of the review should be summarized as a contents section immediately following the Abstract.
Figures: Color figures are welcome; however, they should be submitted only if reproduction in color is intended (a charge will apply). Electronically submitted figures should be saved as .tiff files at a resolution of 300 dpi/in. Color figures should be set to CMYK mode. Figures should be clear, high contrast, and of the size they are to appear in the journal: 8.00 cm (3.15 in) wide for a single column; 17.00 cm (6.70 in) for a double column; maximum height 20.00 cm (7.87 in). Graphs should not require any artwork or typesetting, and symbols, numbering and lettering should be clearly legible and of the appropriate size. The number and top of figures in print should be indicated.
Tables: Each table should be submitted on a separate page, and typed using double-spacing. Tables should be numbered with Roman numerals and should include a short title.
Nomenclature and Abbreviations: Nomenclature should follow that given in Chemical Abstracts. Standard abbreviations are preferable. If a new abbreviation is used, it should be defined at its first usage.
References: Citation of journal titles follow the standard form of Index Medicus and the references must be numbered consecutively. Do NOT use full stop after initials or abbreviations. In the text, references should be cited by number in soft brackets e.g. (1-3) (1,2). Inclusive page numbers should be given. Complete Author list is preferred, however, if more than 7 Authors, 3 names and et al can be used. Following are examples of order and style, which should be strictly adhered to:
1. Spandidos DA and Wilkie NM: Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310: 469-475, 1984.
2. Hall A, Morris JDH, Price B, Lloyd A, Hancock JF, Gardener S, Houslay MD, Wakelam MJO and Marshall CJ: The function of the mammalian Ras proteins. In: Ras oncogenes. Spandidos DA (ed.) Plenum Publ. Corp., New York, pp99-104, 1989.
3. Spandidos A, Wang X, Wang H and Seed B: PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38: D792-D799, 2010.
Personal communications should be avoided. Manuscripts in preparation or submitted, but not yet accepted, and abstracts, may be cited in the text, however should NOT be included in the list of references.
EndNote and Reference Manager output styles for our journals are available. To download the Output Style files, please click on the following link:
Output Styles Download
Conflicts of interest and informed consent: Forms are not used; however, the authors of all submitted manuscripts must declare whether they have any conflicts of interest. Additionally, all submitted manuscripts must include a statement that informed consent, if necessary, was obtained.
Use of humans and experimental animals: Research carried out on humans must follow international and national regulations. When experimental animals are used, research carried out must follow internationally recognised guidelines on animal welfare, as well as local and national regulations. Additionally, a statement must be included in the Materials and methods section of the manuscript, identifying the institutional and/or licensing committee that has approved the experiments undertaken.
Proofs: It is of vital importance that Authors check their manuscripts carefully before submission, because any errors will be faithfully transferred into the typeset version.
Reprints: A reprint order form will accompany notification of acceptance of a manuscript and should be completed and returned immediately.
Page charges: Accepted manuscripts will be published on the understanding that the author(s) will pay the page charges as indicated on submission. An order form with payment details is provided at the proofs stage of manuscript submission. A PDF of the final article is provided free of charge upon publication.
Basic charge (total amount for up to 5 pages): EUR 190
Each additional page : EUR 110
Reproduction in color : EUR 390 per page.
Color figures should only be submitted if intended for publication. Fees for color reproduction are calculated based on the figures at the time of manuscript acceptance. Figures may not be changed to black and white once a manuscript has been accepted.
Open Access: "Open access" indicates that articles published online can be freely accessed at the journal's website by all users. Spandidos Publications Ltd. automatically provides open access to papers a year after their publication online.
Should authors prefer or require their article to be freely available as soon as it has been published, they may request open access immediately upon publication for a fee of EUR 450.
Editorial Board
Editor:
Professor DEMETRIOS A. SPANDIDOS, BSc, PhD, FRCPath, DSc, FRSH, FASA
CV - PUBLICATIONS - THE CANCER STORY
Editorial Board:
J.M. Arencibia, Madrid, Spain
A. Basu, Cleveland, OH, USA
W.Y. Chen, Greenville, SC, USA
A.E. Dear, Melbourne, Australia
S.E. Egan, Toronto, Ontario, Canada
A. Fusco, Napoli, Italy
Y. Gazitt, San Antonio, TX, USA
M. Gnanasekar, Rockford, IL, USA
N.L. Guo, Morgantown, WV, USA
R.C. Gupta, Louisville, KY, USA
R.Hakkak, Little Rock, AR, USA
K. Harigaya, Chiba, Japan
M. Indrová, Prague, Czech Republic
T. Ishiwata, Tokyo, Japan
S. Kanda, Nagasaki, Japan
J.J. Kandel, New York, NY, USA
X. Kang, New York, NY, USA
M. Kashani-Sabet, San Francisco, CA, USA
Y. Kato, Yokosuka, Japan
K. Kiura, Okayama, Japan
H. Koga, Kurume, Japan
A.-N.T. Kong, Piscataway, NJ, USA
D. Kufe, Boston, MA, USA
C.-F Li, Taiwan, R.O.C.
T. Liehr, Jena, Germany
M. Liu, Houston, TX, USA
H.-W. Lo, Durham, NC, USA
A. Loktionov, Cambridge, UK
Y.A. Luqmani, Safat, Kuwait
J.A. Menendez, Girona, Spain
C. Müller-Tidow, Münster, Germany
A. Nakajima, Yokohama, Japan
J. Norgauer, Jena, Germany
N.K. Prasad, West Lafayette, IN, USA
J.S. Rao, Peoria, IL, USA
M. Romani, Genova, Italy
G. Samonis, Heraklion, Greece
S. Saussez, Mons, Belgium
S. Sebens, Kiel, Germany
S. Singhal, Fort Worth, TX, USA
D. Sliva, Indianapolis, IN, USA
W.J. Storkus, Pittsburgh, PA, USA
T. Sumi, Osaka, Japan
F. Tanaka, Nishinomiya, Japan
J.G. Teodoro, Montreal, Quebec, Canada
M. Tsuneoka, Gunma, Japan
M. Urade, Hyogo, Japan
K.-L. Wallin, Stockholm, Sweden
N. Wernert, Bonn, Germany
D.J. Yamashiro, New York, NY, USA
W.-L. Yang, Manhasset, NY, USA
C.-C. Yen, Taipei, Taiwan, R.O.C.
L.-G. Yu, Liverpool, UK
H.-T. Zhang, Suzhou, P.R. China
|
